Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-04-25

Clinical Trial Update: Autofluorescence in Uveitic and Diabetic Macular Edema

View source ↗

Summary

A clinical trial assessing autofluorescence in uveitic and diabetic macular edema has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: St. Franziskus Hospital | Conditions: Uveitis, Macular Edema | Status: WITHDRAWN